BGLC’s Dual-Asset Strategy: 15% Stake in Fidelion and Exclusive ASEAN Rights Signal Ambitious Growth in AI Oncology
Market Chameleon (Thu, 4-Dec 10:11 AM)
BGLC Strikes Regional MRD Testing Deal: Exclusive ASEAN License and Cross-Equity Moves Highlight Ambition
Market Chameleon (Wed, 12-Nov 8:24 AM)
BioNexus Gene Lab Unveils $100 Million Shelf and $20 Million ATM Program—Capital Readiness to Drive Expansion in Precision Medicine
Market Chameleon (Mon, 10-Nov 8:46 AM)
